X

Stay Connected

Sign Up for Updates

network1.png

PPA strives to improve patient health, advance medical innovation and fuel economic growth.

LEARN MORE
network1.png

The PhRMA Foundation supports the research and career endeavors of scientists in drug discovery and development.

LEARN MORE
network1.png

Access Better Coverage educates consumers about the ABCs of health coverage and access to medicines.

LEARN MORE
network1.png

We Work For Health aims to increase awareness by uniting workers throughout the industry.

LEARN MORE
network1.png

Patent protection should always be considered by an inventor during the initial stages of their invention.

LEARN MORE
logo_white_MyOldMeds-New-1.png

Working to spread awareness and education about the importance of secure drug disposal.

LEARN MORE
LTAC_NEW21.png

Many Americans are struggling to afford their medicines and have important questions about their medicine costs. Let's Talk About Cost addresses these questions.

LEARN MORE
logo_white_LTAM.png

There are a lot of conversations in Washington about how to change Medicare Part D, but they aren't always focused on what seniors care about most: affordability and predictability.

LEARN MORE
 
We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

ICYMI: Cancer death rate continues to decline due to treatment advances

By Matthew Norawong  |    January 25, 2023
Earlier this month, the American Cancer Society (ACS) released its annual report, Cancer Statistics 2023, finding the overall cancer mortality rate has declined 33% since peaking in 1991, leading to...   Read More

Sparking conversations — and careers — at the 2nd annual Pathways to Success Summit

By Dr. Steven Thomas  |    December 8, 2022
On September 28-29, 2022, PhRMA hosted the second annual Pathways to Success: Virtual Graduate Summit and Career Expo. This event provided a unique opportunity for students and faculty from diverse...   Read More

How HTA-based price controls could worsen health outcomes and health disparities

By Katie Koziara  |    November 22, 2022
Concerns about the cost of health care have led to calls for the use of health technology assessments or HTAs by the federal government. This would allow government agencies to make important...   Read More

Identifying and addressing health disparities: PhRMA's first chart pack on health equity

By Kristin Williams  |    October 27, 2022
PhRMA is proud to announce the release of its first ever chart pack on health equity. This chart pack contains information on health equity in three sections: (1) A Snapshot of Health Disparities in...   Read More

New comments outline ways to protect patients from health plans and PBMs who profit from patient assistance

By Emilie Signora  |    October 7, 2022
PhRMA submitted comments this week in response to the Department of Health & Human Services (HHS) proposed rule on the Nondiscrimination in Health Programs and Activities. As outlined in our...   Read More

Frazier PhRMA Scholarship awarded to four college-bound students in Philadelphia and DC

By Rachel Weissman  |    August 22, 2022
The Kenneth C. Frazier PhRMA Scholars Program is going strong in 2022—and we are expanding our horizons to a new city. This summer, we are thrilled to announce four new recipients: Arianna...   Read More

You won’t fix what you don’t value: Two reasons why traditional cost-effective analyses can perpetuate health inequities

By Jackie McRae  |    June 16, 2022
A new report from Partnership for Health Analytic Research or PHAR describes how value assessments that use traditional cost-effectiveness analyses can overlook important health disparities and risk...   Read More

Recognizing LGBTQ+ Pride in biopharmaceutical science

By Andrew Powaleny  |    June 9, 2022
June is Pride Month and, like many across the country, we look forward to celebrating the importance of equality and reminding ourselves to continually seek opportunities to make our society more...   Read More

Potential gene therapies bring hope to patients with sickle cell disease

By Katie Koziara  |    June 6, 2022
A recent analysis highlights how potential gene therapies have the potential to dramatically reduce income disparities for patients with sickle cell disease, leading to as much as $21,000 more in...   Read More

Addressing social determinants of health to improve equitable access to medicines

By Jackie McRae  |    May 19, 2022
PhRMA Awards $150,000 to Address Social Determinants of Health:Announcing the Recipients of Round 4 of the PhRMA Collaborative Actions to Reach Equity (CAREs) Grant Program As part of PhRMA’s...   Read More

Search the Catalyst

View Posts by Topic

see all

View Posts by Contributor

View Posts by Date

see all

Subscribe to Email Updates

Trending Posts

Most Popular Posts

Pharmaceutical Research and Manufacturers of America®
950 F Street, NW Suite 300, Washington, DC 20004

Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how
we and third parties use pixel tags, and how that use affects you, visit our privacy policy and review
"1. Information Collection."